National Comprehensive Cancer Network NCCN; NCCN Guidelines Emphasize Patient Preference as Key to S...
National Comprehensive Cancer Network NCCN; NCCN Guidelines Emphasize Patient Preference as Key to Selection of Maintenance Therapy in Follicular Lymphoma
About this item
Full title
Publisher
Atlanta: NewsRx
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
"The NCCN Guidelines include post-remission therapy (radioimmunotherapy consolidation or maintenance rituximab) as an option for patients responding to first-line chemoimmunotherapy," said Dr. [Andrew D. Zelenetz]. "Given the absence of an overall survival benefit, the NHL Guidelines Panel felt the decision to use post-remission therapy has to be m...
Alternative Titles
Full title
National Comprehensive Cancer Network NCCN; NCCN Guidelines Emphasize Patient Preference as Key to Selection of Maintenance Therapy in Follicular Lymphoma
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_892982848
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_892982848
Other Identifiers
ISSN
1543-687X
E-ISSN
1543-6861
